Effect of farnesyltransferase inhibitors on SARS-CoV-2.

ABSTRACT:

Objectives

The emergence of SARS-CoV-2 in 2019 led to a severe pandemic situation. Treatment options are limited, and the efficacy of vaccines decreases due to mutations in SARS-CoV-2 strains. Therefore, new treatment options are urgently needed, and computational compound screenings are used to predict drugs quickly. One of these screenings revealed farnesyltransferase inhibitors (FTIs) as potential candidates.

Methods

SARS-CoV-2 infected Calu-3 cells were treated with lonafarnib and tipifarnib and fold change viral replication of SARS-CoV-2 was measured using RT-qPCR. Furthermore, morphological changes, like CPE formation, were evaluated. Effects on Calu-3 cells were analyzed using MTT assay.

Results

We demonstrated that the FTIs lonafarnib and tipifarnib have an ef

SUBMITTER: Weber L 

PROVIDER: S-EPMC9711904 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature